Arrowhead Pharmaceuticals to Host 2024 Summer Series of R&D Webinars

Arrowhead Pharmaceuticals, Inc. today announced its plan to host a 2024 Summer Series of R&D webinars that highlight multiple clinical stage RNA interference based medicines that utilize the...

Related Keywords

Christopher Anzalone ,Exchange Commission ,Arrowhead Pharmaceuticals ,Nasdaq ,Arrowhead Pharmaceuticals Inc ,Linkedin ,Summer Series ,Series Schedule ,Nervous System ,Harbor Statement ,Private Securities Litigation Reform Act ,Annual Report ,Quarterly Reports ,